Moderna Inc (MRNA)

$117.07 1.12 (0.97%)

16:00 EDT MRNA Stock Quote Delayed 30 Minutes

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

By Shane Neagle, InvestorPlace Contributor Mar 7, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

7 F-Rated Stocks to Sell in March 2024

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

Volume:

Previous Close -

Market Cap 44.84B

PE Ratio -7.48

EPS -15.66

Volume (Avg. Vol.) 3.43M

Day's Range $114.02 - $119.14

52-Week Range $62.55 - $170.47

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short

By Joel Baglole, InvestorPlace Contributor Feb 28, 2024

In recent weeks, stocks have risen and fallen dramatically based on the financial results of the companies behind them. Investor portfolios have been violently jostled by the prints, many of which surprised people on both Wall Street and Main Street.

Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.

By Will Ashworth, InvestorPlace Contributor Feb 19, 2024

Layoffs were a big theme in 2023. Unless the economy drastically picks up in 2024, they could happen this year in large numbers.

ChatGPT Stock Predictions: 3 Companies the AI Bot Thinks Have 10X Potential

By Faizan Farooque, InvestorPlace Contributor Feb 14, 2024

Navigate the stock market with confidence using AI stock predictions. Harness the latest in AI technology for strategic investment planning.

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 11, 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

7 Stocks to Sell as Fast as You Possibly Can

By Louis Navellier and the InvestorPlace Research Staff Feb 8, 2024

Don't be nostalgic about these. Dumping each of these stocks to sell now will go a long way toward saving your portfolio.

3 Stocks Poised to Bounce Back After a Brutal 2023

By Joel Baglole, InvestorPlace Contributor Jan 18, 2024

These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead.

7 Mighty Healthcare Stocks Changing the Game of Medicine

By Josh Enomoto, InvestorPlace Contributor Jan 17, 2024

With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily,…

7 Healthcare Stocks Taking Medicine to the Next Level

By Josh Enomoto, InvestorPlace Contributor Jan 14, 2024

While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio.…

3 Megatrend Stocks that Will Revolutionize Your Portfolio

By Matthew Farley, InvestorPlace Contributor Jan 11, 2024

Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio.

Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 9, 2024

Unveil three standout companies set to double investments by 2025 with groundbreaking strategies in tech and healthcare.

7 S&P 500 Stocks to Buy to Keep the Bull Market Running

By Rich Duprey, InvestorPlace Contributor Jan 9, 2024

The S&P 500 index is approaching a new all-time high and these seven stocks will keep the bull market running.

2 Major Reasons Why Moderna (MRNA) Stock Is Up Today

By Chris MacDonald, InvestorPlace Contributor Jan 2, 2024

One of the most beaten-down stocks of 2023 in the biotech space, Moderna is seeing a rebound today, with MRNA stock up 15%.

The Winners and Losers: 2023 Stock Market Performance Review

By Jeremy Flint, InvestorPlace Contributor Dec 27, 2023

The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).

Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now

By Noah Bolton, InvestorPlace Contributor Dec 19, 2023

Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.

3 S&P 500 Stocks That Are About to Get Absolutely Crushed

By Joel Baglole, InvestorPlace Contributor Dec 16, 2023

Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.

MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer

By Chris MacDonald, InvestorPlace Contributor Dec 14, 2023

Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.

Why Is Moderna (MRNA) Stock Up 11% Today?

By William White, InvestorPlace Writer Dec 14, 2023

Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.

7 F-Rated Stocks to Sell in December

By Louis Navellier and the InvestorPlace Research Staff Dec 8, 2023

Life is short. Time relentlessly moves forward, transforming seconds and minutes into hours and days. Before you know it, it’s nearly the end of 2023…

Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!

By Will Ashworth, InvestorPlace Contributor Nov 20, 2023

Few S&P 500 companies didn’t meet or exceed Q3 2023 earnings estimates. Here are three earnings miss investment opportunities.

6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%

By Rich Duprey, InvestorPlace Contributor Nov 8, 2023

Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth.

Moderna Inc (MRNA)

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

7 F-Rated Stocks to Sell in March 2024

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in